Ghrelin in chronic liver disease (Q44381036)

2 December 2017

title

Ghrelin in chronic liver disease (English)

1 reference

2 December 2017

main subject

chronic liver disease

0 references

Patrick Schöffski

1 reference

2 December 2017

Frank Tacke

1 reference

2 December 2017

Georg Brabant

1 reference

2 December 2017

Elmar Kruck

1 reference

2 December 2017

Rüdiger Horn

1 reference

2 December 2017

Hartmut Hecker

1 reference

2 December 2017

Michael P Manns

1 reference

2 December 2017

Christian Trautwein

1 reference

2 December 2017

publication date

1 April 2003

1 reference

2 December 2017

published in

Journal of Hepatology

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

447-454

1 reference

Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Nutrition and liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

1 reference

7 January 2021

Growth hormone/insulin-like growth factor 1 axis alterations contribute to disturbed protein metabolism in cirrhosis patients after hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Growth hormone therapy in patients with cirrhosis: A pilot study of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Serum insulin-like growth factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Expression of IGF-I and IGF-binding protein genes in cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

The IGF axis and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin Strongly Stimulates Growth Hormone Release in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin enhances appetite and increases food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin gene expression is age-dependent and influenced by gender and the level of circulating IGF-I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Circulating ghrelin levels are decreased in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Circulating ghrelin levels in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

On closed testing procedures with special reference to ordered analysis of variance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

GH/IGF system, cirrhosis and liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Ghrelin drives GH secretion during fasting in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Pathogenesis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

The prognostic significance of clinical and pathological features in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900438-5

7 January 2021

10.1016/S0168-8278(02)00438-5

Identifiers

DOI

1 reference

2 December 2017

1 reference